MBX Biosciences, Inc.
MBX
$8.70
$0.070.81%
09/30/2024 | 06/30/2024 | 03/31/2024 | |||
---|---|---|---|---|---|
Revenue | -- | -- | -- | ||
Total Other Revenue | -- | -- | -- | ||
Total Revenue | -- | -- | -- | ||
Cost of Revenue | -- | -- | -- | ||
Gross Profit | -- | -- | -- | ||
SG&A Expenses | 53.04% | 47.55% | 104.61% | ||
Depreciation & Amortization | -- | -- | -- | ||
Other Operating Expenses | -- | -- | -- | ||
Total Operating Expenses | 79.19% | 108.04% | 109.11% | ||
Operating Income | -79.19% | -108.04% | -109.11% | ||
Income Before Tax | -78.53% | -108.43% | -107.38% | ||
Income Tax Expenses | -- | -- | -- | ||
Earnings from Continuing Operations | -78.53% | -108.43% | -107.38% | ||
Earnings from Discontinued Operations | -- | -- | -- | ||
Extraordinary Item & Accounting Change | -- | -- | -- | ||
Minority Interest in Earnings | -- | -- | -- | ||
Net Income | -78.53% | -108.43% | -107.38% | ||
EBIT | -79.19% | -108.04% | -109.11% | ||
EBITDA | -79.16% | -108.27% | -109.57% | ||
EPS Basic | 70.37% | -64.32% | -47.77% | ||
Normalized Basic EPS | 70.37% | -64.31% | -47.76% | ||
EPS Diluted | 70.37% | -64.32% | -47.77% | ||
Normalized Diluted EPS | 70.37% | -64.31% | -47.76% | ||
Average Basic Shares Outstanding | 502.57% | 26.84% | 40.35% | ||
Average Diluted Shares Outstanding | 502.57% | 26.84% | 40.35% | ||
Dividend Per Share | -- | -- | -- | ||
Payout Ratio | -- | -- | -- |